Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial

Name: Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial
Start: 2022-11-17T00:15:00+05:30
End: 2022-11-17T00:15:00+05:30
Location: Online

November 17, 2022 @ 12:15 am